A Study of BI 3810944 in Patients With Advanced Cancer

Clinical trial NCT07224425 · RECRUITING

Trial details

NCT number: NCT07224425
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumours Melanoma

Start date: 2026-02-24
Primary completion: 2029-10-05
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.